These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19288855)

  • 1. Complement-mediated bactericidal effect of antibodies in human intravenous preparation against multi-drug resistant pseudomonas aeruginosa.
    Nakae T; Tanaka J; Nakano A; Ono Y
    Jpn J Antibiot; 2008 Dec; 61(6):379-87. PubMed ID: 19288855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated bacteriolysis after binding of specific antibodies to drug-resistant Pseudomonas aeruginosa: morphological changes observed by using a field emission scanning electron microscope.
    Tanaka J; Nakae T; Onoe T; Horiuchi Y; Miyamoto H; Adan-Kubo J; Adachi H; Ono Y
    J Infect Chemother; 2010 Dec; 16(6):383-7. PubMed ID: 20532941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opsonizing activity of human immunoglobulin preparations for intravenous use (IVIG)].
    Banach W; Bucholc B
    Med Dosw Mikrobiol; 1994; 46(4):349-55. PubMed ID: 7603135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad.
    Xie X; McLean MD; Hall JC
    J Immunol; 2010 Apr; 184(7):3725-33. PubMed ID: 20190144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bactericidal activity of human, swine and cattle serum against pseudomonas aeruginosa strains].
    Wolska K; Bukowski K; Anusz Z; Jakubczak A
    Med Dosw Mikrobiol; 1999; 51(3-4):339-45. PubMed ID: 10803263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.
    Matsuo H; Itoh H; Kitamura N; Kamikubo Y; Higuchi T; Shiga S; Ichiyama S; Kondo T; Takaori-Kondo A; Adachi S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):94-9. PubMed ID: 26119690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
    Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
    J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibody-enzyme conjugates with specific bactericidal activity.
    Knowles DM; Sulivan TJ; Parker CW; Williams RC
    J Clin Invest; 1973 Jun; 52(6):1443-52. PubMed ID: 4145026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.
    Itoh H; Matsuo H; Kitamura N; Yamamoto S; Higuchi T; Takematsu H; Kamikubo Y; Kondo T; Yamashita K; Sasada M; Takaori-Kondo A; Adachi S
    J Leukoc Biol; 2015 Jul; 98(1):107-17. PubMed ID: 25908735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
    Guttman RM; Waisbren BA
    Clin Exp Immunol; 1975 Jan; 19(1):121-30. PubMed ID: 54231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity in filtrated supernatant of Streptococcus sanguinis against multidrug-resistant Pseudomonas aeruginosa.
    Watanabe K; Senba M; Ichinose A; Yamamoto T; Ariyoshi K; Matsumoto K
    Tohoku J Exp Med; 2009 Oct; 219(2):79-84. PubMed ID: 19776523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.